Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL8975868

CC(Cc1ccccc1)c1cccc([N+](=O)[O-])c1.N

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
HTT P42858 1/20 0.53
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
HPGD P15428 1/20 0.52
ACP3 P15309 1/20 0.50
CYP2C19 P33261 3/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C9 P11712 2/20 0.49
TSHR P16473 2/20 0.47
LMNA P02545 1/20 0.46
OPRM1 P35372 1/20 0.46
OPRK1 P41145 1/20 0.46
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
NPC1 O15118 1/20 0.45
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL8867125 0.91 CYP2D6 (0.52) SMN1; SMN2L3MBTL1HTTKMT2AMEN1
Fumaric Acid SCHEMBL8866686 0.91 SMN1; SMN2 (0.52) SMN1; SMN2L3MBTL1HTTKMT2AMEN1
Formamide SCHEMBL8868988 0.83 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1HTTKMT2AMEN1
Fumaric Acid SCHEMBL8866888 0.83 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1HTTKMT2AMEN1
SCHEMBL16396155 0.82 SMN1; SMN2 (0.59) SMN1; SMN2L3MBTL1HTTKMT2AMEN1
SCHEMBL7008328 0.81 KMT2A (0.55) SMN1; SMN2HTTKMT2AMEN1CYP2C19
SCHEMBL18896279 0.80 KMT2A (0.58) SMN1; SMN2L3MBTL1HTTKMT2AMEN1
SCHEMBL21200551 0.78 L3MBTL1 (0.61) SMN1; SMN2L3MBTL1HTTKMT2AMEN1
SCHEMBL2878386 0.78 L3MBTL1 (0.61) SMN1; SMN2L3MBTL1HTTKMT2AMEN1
SCHEMBL11810361 0.78 KMT2A (0.57) SMN1; SMN2L3MBTL1HTTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5539120-A Arylalkyl-amines having anticonvulsant and neuroprotective properties AGENCE SPATIALE EUROPEENNE (FR) 1996-07-23 US claimed
EP-0356035-B1 Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties ASTRA AB (SE) 1996-03-13 EP claimed
WO-1991011995-A1 ARYLALKYL-AMINES AND -AMIDES HAVING ANTICONVULSANT AND NEUROPROTECTIVE PROPERTIES FISONS CORPORATION (US) 1991-08-22 WO claimed
EP-0356035-A2 Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties Astra Aktiebolag (SE) 1990-02-28 EP claimed